EUVIMEDEUVIMED entdecken
Crossref

Survivin and Ki-67 immunohistochemical expression in penile squamous cell carcinoma: clinicopathological features and overall survival

Mateus W De Bacco, Iago Z Pires, Josenel M B Marçal, Mário B Wagner, André P Fay, Márcio A Averbeck, Gustavo F Carvalhal

International Urology and Nephrology · 21.07.2025 · 58 (2) · 467-475

DOI: 10.1007/s11255-025-04672-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Urology and Nephrology, online erschienen am 21.07.2025. Verfasst von Mateus W De Bacco und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, São Lucas Hospital, Pontifical Catholic University of Rio Grande Do Sul, Porto Alegre, 90619-900, Brazil. Hauptthemen laut MEDLINE: Survivin, Ki-67 Antigen, Carcinoma, Squamous Cell, Penile Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 33 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: The present study evaluated Survivin and Ki-67 immunohistochemical expression in squamous cell carcinoma of the penis and its association with clinicopathological features and outcomes. PATIENTS AND METHODS: A retrospective cohort study, from 1998 to 2016, was conducted at a tertiary hospital in Brazil, utilizing a convenience sample. The study collected clinical characteristics, pathological features, and outcomes. Immunohistochemical expressions of Survivin and Ki-67 were performed on formalin-fixed paraffin-embedded specimens from patients with PSCC. Survivin positivity (Survivin +) was defined as any staining in more than 5% of tumor cells, while Ki-67 positivity was defined as any staining in more than 10%. The Mann-Whitney U test and Fisher's exact test were used to perform the associations. Kaplan-Meier curves with log-rank were used to estimate survival. RESULTS: Forty patients undergoing partial or total penectomy were selected, with five subsequently excluded. Among the remaining 35 patients, 15 (42.8%) were Ki-67 positive, and 9 (25.7%) were Survivin + . Ki-67 expression did not demonstrate association with higher tumor grade (73.3% for grades II and III vs. 55% for grade II in the Ki-67 < 10% group; p = 0.06), larger lesions (p = 0.05), or survival outcomes (HR 1.66; 95% CI 0.56-4.98; p = 0.36). Survivin + was more common in grade II and III than grade I (77.8% vs. 22.1; p = 0.027), and Survivin + patients were correlated with worse overall survival (HR 3.73; 95%CI 1.25-11.12; p = 0.01). CONCLUSION: Ki-67 expression does not seem to have an impact on clinicopathological features and overall survival. The expression of survivin seems to be promising in detecting penile squamous cell carcinoma patients with a worse prognosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SurvivinKi-67 AntigenCarcinoma, Squamous CellPenile NeoplasmsHumansMaleRetrospective StudiesMiddle AgedAgedImmunohistochemistrySurvival RateAdultBiomarkers, TumorPrognosis

Stichwörter der Autor:innen

BiomarkersImmunohistochemistryImmunotherapyPenile cancerPrognosis

Substanzen

SurvivinKi-67 AntigenBIRC5 protein, humanBiomarkers, Tumor

Autor:innen und Institutionen

  • Department of Urology, São Lucas Hospital, Pontifical Catholic University of Rio Grande Do Sul, Porto Alegre, 90619-900, Brazil.
  • School of Medicine, Pontifical Catholic University of Rio Grande Do Sul, Porto Alegre, 90619-900, Brazil. i.zang@edu.pucrs.br.
  • Department of Pathology, São Lucas Hospital, Pontifical Catholic University of Rio Grande Do Sul, Porto Alegre, 90619-900, Brazil.
  • Department of Biostatistics, São Lucas Hospital, Pontifical Catholic University of Rio Grande Do Sul, Porto Alegre, 90619-900, Brazil.
  • Department of Urology, São Lucas Hospital, Pontifical Catholic University of Rio Grande Do Sul, Porto Alegre, 90619-900, Brazil. gcarvalhal@terra.com.br.
  • School of Medicine, Pontifical Catholic University of Rio Grande Do Sul, Porto Alegre, 90619-900, Brazil. gcarvalhal@terra.com.br.

Zitieren

APA

De Bacco, M. W., Pires, I. Z., Marçal, J. M. B., Wagner, M. B., Fay, A. P., Averbeck, M. A., & Carvalhal, G. F. (2025). Survivin and Ki-67 immunohistochemical expression in penile squamous cell carcinoma: clinicopathological features and overall survival. International Urology and Nephrology, 58(2), 467-475. https://doi.org/10.1007/s11255-025-04672-2

Vancouver

De Bacco MW, Pires IZ, Marçal JMB, Wagner MB, Fay AP, Averbeck MA, et al. Survivin and Ki-67 immunohistochemical expression in penile squamous cell carcinoma: clinicopathological features and overall survival. International Urology and Nephrology. 2025;58(2):467-475. doi:10.1007/s11255-025-04672-2

BibTeX
@article{DeBacco2025,
  author = {De Bacco, Mateus W and Pires, Iago Z and Marçal, Josenel M B and Wagner, Mário B and Fay, André P and Averbeck, Márcio A and Carvalhal, Gustavo F},
  title = {Survivin and Ki-67 immunohistochemical expression in penile squamous cell carcinoma: clinicopathological features and overall survival},
  journal = {International Urology and Nephrology},
  year = {2025},
  volume = {58},
  number = {2},
  pages = {467--475},
  doi = {10.1007/s11255-025-04672-2}
}
Kostenlos starten →